In addition to saving BIG PHARMA money from early stage tests screening out toxic drugs in their pipeline MUCH EARLIER than current testing methods...
USING ONVO bioprinted assays no doubt will go a long way toward ending...
ambulance-chaser class-action BAD DRUG lawsuits which cost BP added millions in either premiums or settlements,
and eliminate a lot of annoying tv advertising!
Not to mention WIDER USE of ONVO biprinted testing assays might save some people from REAL INJURY caused by marginally safe drugs that do manage to slip through current testing screens and go on to cause injury to a few patients before REAL side-effect DANGERS can be discovered and assessed!!
Market Data 
Markets 
AI
